Evidence map›Paper›PMID 20145387›Full record

ArticleRespiration; international review of thoracic diseases2010

Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Seok-Yong Eum, Ye-Jin Lee, Jin-Hong Min, Hyun-Kyung Kwak, Min-Sun Hong, Ji-Hye Kong, Soo-Hee Hwang, Seung-Kyu Park, Jason J Leblanc, Laura E Via and 2 more

Abstract read
In one paragraph

Article in Respiration; international review of thoracic diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Seok-Yong EumDivision of Immunopathology and Cellular Immunology, and of Molecular Microbiology, International Tuberculosis Research Center, Masan, Republic of Korea. syeumkr @ gmail.com
Ye-Jin Lee
Jin-Hong Min
Hyun-Kyung Kwak
Min-Sun Hong
Ji-Hye Kong
Soo-Hee Hwang
Seung-Kyu Park
Jason J Leblanc
Laura E Via
Clifton E Barry
Sang-Nae Cho

Funding

International Research in Korea: Clinical Studies of Drug-Resistant TuberculosisZIAAI001067 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2017
$6.9M
6 · The paper itself

Abstract

backgroundWe have previously reported that TNF-α levels correlate to total mycobacterial burden in tuberculosis (TB) patients.

objectiveTo characterize the dynamics of cytokine responses in TB patients during chemotherapy to identify potential surrogate markers for effective treatment.

methodsFollowing induction by culture filtrate proteins in whole blood, production patterns of TNF-α, IL-10, IFN-γ and IL-12 were measured in 23 non-multidrug-resistant (MDR)-TB and 16 MDR-TB patients and in 31 healthy controls. Rates of mycobacterial clearance from the sputum were then measured and compared.

resultsPrior to the initiation of chemotherapy, TNF-α and IL-10 levels were significantly higher in TB patients than in healthy controls while IFN-γ and IL-12 levels were similar. During chemotherapy, the levels of all 4 cytokines increased. We evaluated these responses separately in patients that did and did not clear their sputum culture at 2 and 6 months. At 2 months, decreases in both IFN-γ and IL-12 correlated strongly with a successful early response, while after 6 months of therapy, when half (7/14) of MDR-TB patients were still sputum culture positive, downregulation of TNF-α was uniquely correlated with sputum conversion between the groups.

conclusionOur findings suggest the possibility that the regulation of TNF-α production in whole blood may be a more specific indicator of sputum conversion at 6 months than IFN-γ, IL-12 or IL-10 in MDR-TB patients.

Indexed as

AdultAgedAged, 80 and overAntitubercular AgentsBiomarkersCase-Control StudiesFemaleHumansInterferon-gammaInterleukin-10Interleukin-12MaleMiddle AgedMycobacterium tuberculosisSputumTuberculosis, Multidrug-ResistantAntitubercular AgentsBiomarkersIL10 protein, humanInterferon-gammaInterleukin-10Interleukin-12Tumor Necrosis Factor-alpha

Identifiers

PMID20145387
PMCPMC2955738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.